Rare but relevant: Hydrocarbons and sudden sniffing syndrome
Addiction, EarlyView.Abstract Inhaled hydrocarbon‐associated sudden collapse (IHASC), often referred to as ‘sudden sniffing death syndrome’ is a critical and often fatal event linked to the inhalation of volatile hydrocarbons, primarily occurring in adolescents and young adults. This syndrome manifests as sudden cardiac and/or respiratory arrest, typically occurring during
Ingrid Berling +1 more
wiley +1 more source
Referring children to an ENT department and prescribing psychotropic drugs to their mothers. [PDF]
, 1981 D J Bain, Célia M. D. Sales
openalex +1 more source
Age–period–cohort analysis of past 12‐month cannabis use in Germany (1995–2021)
Addiction, EarlyView.Abstract Background and Aims In 2024, cannabis was partially legalized for recreational purposes in Germany. With a growing prevalence of persons who used cannabis in the past 12 months, and the health risks associated with cannabis use, it is imperative to examine usage behavior patterns in greater detail.
Natalie S. Schöllner +5 more
wiley +1 more source
Impact of the COVID-19 health crisis on psychotropic drug use in children and adolescents in France. [PDF]
Child Adolesc Psychiatry Ment HealthCouturas J +7 more
europepmc +1 more source
Psychotropic drug treatment for agitated behaviour in dementia: what if the guideline prescribing recommendations are not sufficient? A qualitative study. [PDF]
Age Ageing, 2022 Dijk MT +7 more
europepmc +1 more source
Synthetic cannabinoids in e‐cigarettes seized from English schools
Addiction, EarlyView.Abstract Background and aims People who use synthetic cannabinoids (SCs) report debilitating side effects and withdrawal symptoms, coupled with dependence. In the UK, SC use was believed to be largely restricted to prison, where they are the most common drug and associated with nearly half of non‐natural deaths, or poly‐drug users in the community who ...
Gyles E. Cozier +17 more
wiley +1 more source
Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage +3 more
wiley +1 more source
Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993-2016. [PDF]
Ann Gen PsychiatrySeifert J +7 more
europepmc +1 more source